These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27659719)

  • 1. Methodological issues associated with clinical trials in neuropathic pain.
    Gilron I
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1399-1402. PubMed ID: 27659719
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial.
    Delage N; Morel V; Picard P; Marcaillou F; Pereira B; Pickering G
    Trials; 2017 Nov; 18(1):517. PubMed ID: 29100524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing neuropathic pain: first expert recommendation for South Africa places emphasis on stepwise pharmacological intervention.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):351-2. PubMed ID: 23091828
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
    Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
    Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine for the treatment of general neuropathic pain: a narrative review.
    Pickering G; Morel V
    Fundam Clin Pharmacol; 2018 Feb; 32(1):4-13. PubMed ID: 28802070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropathic pain. Basic principles for successful therapy].
    Tölle TR; Baron R
    MMW Fortschr Med; 2002 May; 144(21):41-4. PubMed ID: 12134424
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine for neuropathic pain: a tiger that won't bite?
    Dahan A; van Velzen M; Niesters M
    Br J Anaesth; 2020 Sep; 125(3):e275-e276. PubMed ID: 32536446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and tolerability of gabapentin in the treatment of patients with neuropathic pain. Results of an observational study involving 5620 patients].
    Junker U; Brunnmüller U
    MMW Fortschr Med; 2003 Oct; 145(44):37. PubMed ID: 14655505
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 13. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.
    Gilron I; Bailey JM; Tu D; Holden RR; Jackson AC; Houlden RL
    Lancet; 2009 Oct; 374(9697):1252-61. PubMed ID: 19796802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions].
    Mallison R; Tilke C; Brasser M; Pittrow D
    MMW Fortschr Med; 2007 Apr; 149(14):46. PubMed ID: 17668764
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing adaptive design for Phase 2 dose-finding trials incorporating long-term success and financial considerations: A case study for neuropathic pain.
    Gao J; Nangia N; Jia J; Bolognese J; Bhattacharyya J; Patel N
    Contemp Clin Trials; 2017 Jun; 57():69-86. PubMed ID: 28385653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the drug treatment of neuropathic pain. Part 2: antiepileptics and other drugs.
    Drug Ther Bull; 2012 Nov; 50(11):126-9. PubMed ID: 23154593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic back pain--assessing the origin of neuropathic components of pain].
    MMW Fortschr Med; 2008 Aug; 150(32-35):60-1. PubMed ID: 19009701
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.
    Ney JP; Devine EB; Watanabe JH; Sullivan SD
    Pain Med; 2013 May; 14(5):706-19. PubMed ID: 23691937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.